196 related articles for article (PubMed ID: 31271354)
1. Persistent inflammation during anti-tuberculosis treatment with diabetes comorbidity.
Kumar NP; Fukutani KF; Shruthi BS; Alves T; Silveira-Mattos PS; Rocha MS; West K; Natarajan M; Viswanathan V; Babu S; Andrade BB; Kornfeld H
Elife; 2019 Jul; 8():. PubMed ID: 31271354
[TBL] [Abstract][Full Text] [Related]
2. Slow radiological improvement and persistent low-grade inflammation after chemotherapy in tuberculosis patients with type 2 diabetes.
Mily A; Sarker P; Taznin I; Hossain D; Haq MA; Kamal SMM; Agerberth B; Brighenti S; Raqib R
BMC Infect Dis; 2020 Dec; 20(1):933. PubMed ID: 33287713
[TBL] [Abstract][Full Text] [Related]
3. Diabetes mellitus is associated with increased mortality during tuberculosis treatment: a prospective cohort study among tuberculosis patients in South-Eastern Amahra Region, Ethiopia.
Workneh MH; Bjune GA; Yimer SA
Infect Dis Poverty; 2016 Mar; 5():22. PubMed ID: 27009088
[TBL] [Abstract][Full Text] [Related]
4. Diabetes mellitus is associated with cavities, smear grade, and multidrug-resistant tuberculosis in Georgia.
Magee MJ; Kempker RR; Kipiani M; Gandhi NR; Darchia L; Tukvadze N; Howards PP; Narayan KM; Blumberg HM
Int J Tuberc Lung Dis; 2015 Jun; 19(6):685-92. PubMed ID: 25946360
[TBL] [Abstract][Full Text] [Related]
5. Plasma Eicosanoid Levels in Tuberculosis and Tuberculosis-Diabetes Co-morbidity Are Associated With Lung Pathology and Bacterial Burden.
Pavan Kumar N; Moideen K; Nancy A; Viswanathan V; Shruthi BS; Shanmugam S; Hissar S; Kornfeld H; Babu S
Front Cell Infect Microbiol; 2019; 9():335. PubMed ID: 31632923
[TBL] [Abstract][Full Text] [Related]
6. Systems Immunology of Diabetes-Tuberculosis Comorbidity Reveals Signatures of Disease Complications.
Prada-Medina CA; Fukutani KF; Pavan Kumar N; Gil-Santana L; Babu S; Lichtenstein F; West K; Sivakumar S; Menon PA; Viswanathan V; Andrade BB; Nakaya HI; Kornfeld H
Sci Rep; 2017 May; 7(1):1999. PubMed ID: 28515464
[TBL] [Abstract][Full Text] [Related]
7. Modulation of dendritic cell and monocyte subsets in tuberculosis-diabetes co-morbidity upon standard tuberculosis treatment.
Kumar NP; Moideen K; Sivakumar S; Menon PA; Viswanathan V; Kornfeld H; Babu S
Tuberculosis (Edinb); 2016 Dec; 101():191-200. PubMed ID: 27865391
[TBL] [Abstract][Full Text] [Related]
8. Systemic RAGE ligands are upregulated in tuberculosis individuals with diabetes co-morbidity and modulated by anti-tuberculosis treatment and metformin therapy.
Kumar NP; Moideen K; Nancy A; Viswanathan V; Shruthi BS; Sivakumar S; Hissar S; Kornfeld H; Babu S
BMC Infect Dis; 2019 Dec; 19(1):1039. PubMed ID: 31818258
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Systemic Inflammation Before and After Standard Anti-tuberculosis Treatment in Patients With Active Pulmonary Tuberculosis and Diabetes Mellitus.
López-González JA; Martínez-Soto JM; Avila-Cervantes C; Mata-Pineda AL; Álvarez-Hernández G; Álvarez-Meza JB; Bolado-Martínez E; Candia-Plata MDC
Cureus; 2024 Mar; 16(3):e55391. PubMed ID: 38562330
[TBL] [Abstract][Full Text] [Related]
10. Sputum conversion at the end of intensive phase of Category-1 regimen in the treatment of pulmonary tuberculosis patients with diabetes mellitus or HIV infection: An analysis of risk factors.
Banu Rekha VV; Balasubramanian R; Swaminathan S; Ramachandran R; Rahman F; Sundaram V; Thyagarajan K; Selvakumar N; Adhilakshmi AR; Iliayas S; Narayanan PR
Indian J Med Res; 2007 Nov; 126(5):452-8. PubMed ID: 18160750
[TBL] [Abstract][Full Text] [Related]
11. Diabetes Is Associated with Worse Clinical Presentation in Tuberculosis Patients from Brazil: A Retrospective Cohort Study.
Gil-Santana L; Almeida-Junior JL; Oliveira CA; Hickson LS; Daltro C; Castro S; Kornfeld H; Netto EM; Andrade BB
PLoS One; 2016; 11(1):e0146876. PubMed ID: 26752596
[TBL] [Abstract][Full Text] [Related]
12. Plasma heme oxygenase-1 levels distinguish latent or successfully treated human tuberculosis from active disease.
Andrade BB; Pavan Kumar N; Mayer-Barber KD; Barber DL; Sridhar R; Rekha VV; Jawahar MS; Nutman TB; Sher A; Babu S
PLoS One; 2013; 8(5):e62618. PubMed ID: 23671613
[TBL] [Abstract][Full Text] [Related]
13. Association of Plasma Matrix Metalloproteinase and Tissue Inhibitors of Matrix Metalloproteinase Levels With Adverse Treatment Outcomes Among Patients With Pulmonary Tuberculosis.
Kumar NP; Moideen K; Nancy A; Viswanathan V; Thiruvengadam K; Sivakumar S; Hissar S; Nair D; Banurekha VV; Kornfeld H; Babu S
JAMA Netw Open; 2020 Dec; 3(12):e2027754. PubMed ID: 33258908
[TBL] [Abstract][Full Text] [Related]
14. Glucose Metabolism Disorder Is Associated with Pulmonary Tuberculosis in Individuals with Respiratory Symptoms from Brazil.
Almeida-Junior JL; Gil-Santana L; Oliveira CA; Castro S; Cafezeiro AS; Daltro C; Netto EM; Kornfeld H; Andrade BB
PLoS One; 2016; 11(4):e0153590. PubMed ID: 27078026
[TBL] [Abstract][Full Text] [Related]
15. Fixed-dose combination associated with faster time to smear conversion compared to separate tablets of anti-tuberculosis drugs in patients with poorly controlled diabetes and pulmonary tuberculosis in Qatar.
Al-Shaer MH; Elewa H; Alkabab Y; Nazer LH; Heysell SK
BMC Infect Dis; 2018 Aug; 18(1):384. PubMed ID: 30089476
[TBL] [Abstract][Full Text] [Related]
16. Changes in inflammatory protein and lipid mediator profiles persist after antitubercular treatment of pulmonary and extrapulmonary tuberculosis: A prospective cohort study.
Vinhaes CL; Oliveira-de-Souza D; Silveira-Mattos PS; Nogueira B; Shi R; Wei W; Yuan X; Zhang G; Cai Y; Barry CE; Via LE; Fukutani KF; Andrade BB; Mayer-Barber KD
Cytokine; 2019 Nov; 123():154759. PubMed ID: 31226436
[TBL] [Abstract][Full Text] [Related]
17. Diabetes mellitus and tuberculosis: pattern of tuberculosis, two-month smear conversion and treatment outcomes in Guangzhou, China.
Mi F; Tan S; Liang L; Harries AD; Hinderaker SG; Lin Y; Yue W; Chen X; Liang B; Gong F; Du J
Trop Med Int Health; 2013 Nov; 18(11):1379-85. PubMed ID: 24112411
[TBL] [Abstract][Full Text] [Related]
18. Significance of the frequency of CD4+CD25+CD127- T-cells in patients with pulmonary tuberculosis and diabetes mellitus.
Sun Q; Zhang Q; Xiao H; Cui H; Su B
Respirology; 2012 Jul; 17(5):876-82. PubMed ID: 22524702
[TBL] [Abstract][Full Text] [Related]
19. Effect of Diabetes Mellitus on the Pharmacokinetics and Pharmacodynamics of Tuberculosis Treatment.
Alfarisi O; Mave V; Gaikwad S; Sahasrabudhe T; Ramachandran G; Kumar H; Gupte N; Kulkarni V; Deshmukh S; Atre S; Raskar S; Lokhande R; Barthwal M; Kakrani A; Chon S; Gupta A; Golub JE; Dooley KE
Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30126955
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and Clinical Profiling of Dysglycemia and HIV Infection in Persons With Pulmonary Tuberculosis in Brazil.
Arriaga MB; Araújo-Pereira M; Barreto-Duarte B; Sales C; Miguez-Pinto JP; Nogueira EB; Nogueira BMF; Rocha MS; Souza AB; Benjamin A; de Oliveira JG; Moreira ASR; Queiroz ATL; Rodrigues MMS; Spener-Gomes R; Figueiredo MC; Durovni B; Cavalcante S; Lapa-E-Silva JR; Kristki AL; Cordeiro-Santos M; Sterling TR; Rolla VC; Andrade BB;
Front Med (Lausanne); 2021; 8():804173. PubMed ID: 35127760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
